This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Interrelationship in Inflammatory Dermatoses: the Clinical Features

JOHN H. STOKES, M.D.; HERMAN BEERMAN, M.D.

Arch Derm Syphilol. 1949;60(2):261-271.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN A SERIES of scattered papers based on observations covering three decades and intensified in the past ten years, Stokes and his associates have outlined a concept of infection allergy which, when applied to the inflammatory dermatoses as an explanation of onsets, relapse and noncure, they have called the virus-pyogen sensitization sequence. The effort is comparable to the of Milian¹ in outlining the biotropic concept of the activation of infections by drugs with the production of certain types of so-called drug eruptions. To this related field certain observational contributions have been made, particularly in the matter of arsenical exfoliative dermatitis, by Stokes and Cathcart² and Stokes and Kulchar.³ Stokes and Callaway⁴ pointed out the types of pyogenic relapse that seemed to follow clinical virus infections, including the epizootic seasonal type, often after a lag, or refractory period, of seven to eleven days, following which the . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA

From the Graduate School of Medicine of the University of Pennsylvania.

Footnotes
Read at the Sixty-Ninth Annual Meeting of the American Dermatological Association, Inc., Hot Springs, Va., May 25-28, 1949.

This article has been abbreviated in the Archives by omission of some reports of cases; the complete text will appear in the authors' reprints.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?